Furthermore, to specifically assess the impact of CPVT RyR2 mutations, we employed a KI mouse model expressing a CPVT-linked human RyR2 mutation R4496C that enhances channel function2,27–30. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.